Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
46.96
-0.36 (-0.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of $5.97 billion as of December 20, 2024. Its market cap has increased by 12.65% in one year.
Market Cap
5.97B
Enterprise Value
6.84B
1-Year Change
12.65%
Ranking
Category
Stock Price
$46.96
Market Cap Chart
Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $5.97B, an increase of 73,660.25%. That is a compound annual growth rate of 37.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.97B | 22.37% |
| Dec 29, 2023 | 4.88B | -36.54% |
| Dec 30, 2022 | 7.69B | 35.91% |
| Dec 31, 2021 | 5.66B | -1.95% |
| Dec 31, 2020 | 5.77B | 122.23% |
| Dec 31, 2019 | 2.60B | 22.85% |
| Dec 31, 2018 | 2.11B | -26.67% |
| Dec 29, 2017 | 2.88B | 125.43% |
| Dec 30, 2016 | 1.28B | -42.33% |
| Dec 31, 2015 | 2.22B | 83.35% |
| Dec 31, 2014 | 1.21B | -29.21% |
| Dec 31, 2013 | 1.71B | 126.01% |
| Dec 31, 2012 | 756.30M | -23.30% |
| Dec 30, 2011 | 986.10M | 23.98% |
| Dec 31, 2010 | 795.40M | 47.84% |
| Dec 31, 2009 | 538.00M | 17.96% |
| Dec 31, 2008 | 456.10M | -17.36% |
| Dec 31, 2007 | 551.90M | 6.38% |
| Dec 29, 2006 | 518.80M | 469.48% |
| Dec 30, 2005 | 91.10M | -13.07% |
| Dec 31, 2004 | 104.80M | 1,193.83% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.36B |
| Madrigal Pharmaceuticals | 6.35B |
| Bausch + Lomb | 6.31B |
| Grifols | 6.29B |
| Legend Biotech | 6.15B |
| Waystar Holding | 6.05B |
| Nuvalent | 5.99B |
| Stevanato Group | 5.94B |